Delivery Order SPE2DB22D2206-SPE2DB25FHP03
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules, with a firm fixed price of $2,599.66 and a completion date of June 26, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,802.45, is for the delivery of 4,568,101,166 units of the prescription medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,308.91 firm fixed-price contract is for the delivery of 4,567,644,043 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,823.76, is for the supply of 100 capsules of the medication Vyvanse (60 mg). It is a firm-fixed-price delivery order contract with a performance period through June 30, 2025. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,454.99, is for the delivery of 4,567,962 units of the prescription medication Vyvanse 40 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. It is not designated as a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,381.58 firm fixed-price contract is for the delivery of 4,567,168,394 units of the prescription medication Vyvanse 50 mg capsules. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,159.44, is for the delivery of 100 units of the prescription medication Vyvanse 50 mg capsules. The contract is a firm fixed-price delivery order, with a completion date of May 16, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,883.98, is for the delivery of 100 units of the prescription drug Vyvanse 50 mg capsules. The contract is a firm fixed-price, non-set-aside award with a completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,134.19 firm-fixed-price contract is for the supply of Vyvanse 40mg capsules. It is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables AmerisourceBergen to deliver a comprehensive range of medical commodities to support military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,301.30, is for the delivery of 100 units of the prescription medication Vyvanse 60 mg capsules. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp, a for-profit organization, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...